Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-21 Purchase | 2026-01-22 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 10,000 | $0.9975 | $9,975 | 798,460 (Direct) | View |
| 2025-12-31 Purchase | 2026-01-05 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 9,795 | $0.86 | $8,424 | 788,460 (Direct) | View |
| 2025-12-30 Purchase | 2026-01-02 5:00 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 205 | $0.826 | $169 | 778,665 (Direct) | View |
| 2025-12-18 Purchase | 2025-12-22 07:00 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 5,000 | $0.9013 | $4,507 | 340,040 (Direct) | View |
| 2025-12-17 Purchase | 2025-12-19 07:00 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 5,000 | $0.8524 | $4,262 | 335,040 (Direct) | View |
| 2025-12-16 Purchase | 2025-12-17 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 12,000 | $0.85 | $10,200 | 778,460 (Direct) | View |
| 2025-12-05 Purchase | 2025-12-08 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 10,000 | $0.96 | $9,600 | 766,460 (Direct) | View |
| 2025-11-21 Purchase | 2025-11-24 6:00 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 22,000 | $0.8 | $17,600 | 756,460 (Direct) | View |
| 2025-08-22 Purchase | 2025-08-26 06:10 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 10,000 | $0.92965 | $9,297 | 330,040 (Direct) | View |
| 2025-06-05 Purchase | 2025-06-09 06:03 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 21,000 | $1.4 | $29,400 | 734,460 (Direct) | View |
| 2025-04-15 Purchase | 2025-04-17 06:10 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 15,000 | $0.9 | $13,500 | 1,113,460 (Direct) | View |
| 2025-04-15 Purchase | 2025-04-16 06:08 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 7,500 | $0.9095 | $6,821 | 320,040 (Direct) | View |
| 2025-04-11 Purchase | 2025-04-14 06:30 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 20,000 | $0.8 | $16,000 | 1,098,460 (Direct) | View |
| 2025-04-08 Purchase | 2025-04-10 7:02 pm | RenovoRx Inc. | RNXT | Kocak Ron VP Controller and PAO | 12,595 | $0.79484 | $10,011 | 12,595 (Direct) | View |
| 2025-04-09 Purchase | 2025-04-10 4:30 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 30,000 | $0.8133 | $24,399 | 1,078,460 (Direct) | View |
| 2025-04-09 Purchase | 2025-04-10 06:02 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 10,000 | $0.83 | $8,300 | 312,540 (Direct) | View |
| 2025-04-08 Purchase | 2025-04-09 9:30 pm | RenovoRx Inc. | RNXT | Marton Laurence Director | 12,050 | $0.848 | $10,218 | 45,684 (Direct) | View |
| 2025-04-08 Purchase | 2025-04-09 12:45 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 26,000 | $0.84 | $21,840 | 1,048,460 (Direct) | View |
| 2025-04-07 Purchase | 2025-04-08 11:30 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 10,000 | $0.83 | $8,300 | 302,540 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-01 Option Award | 2025-10-03 09:19 am | N/A 2035-10-01 | RenovoRx Inc. | RNXT | Marton Laurence Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 8:23 pm | N/A 2035-10-01 | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 8:17 pm | N/A 2035-10-01 | RenovoRx Inc. | RNXT | RYAN UNA S Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 8:10 pm | N/A 2035-10-01 | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 63,636 | $0 | 63,636 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 102,498 | $0 | 102,498 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 6,619 | $0 | 6,619 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 41,600 | $0 | 41,600 (Direct) | View |
| 2025-04-22 Gift | 2025-06-06 5:15 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 400,000 | $0 | 713,460 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-06 4:10 pm | N/A N/A | RenovoRx Inc. | RNXT | Marton Laurence Director | 20,480 | $0.15 | 66,164 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-06 4:10 pm | N/A 2025-10-14 | RenovoRx Inc. | RNXT | Marton Laurence Director | 20,480 | $0 | 66,164 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 409,992 | $0 | 409,992 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 26,477 | $0 | 26,477 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 166,400 | $0 | 166,400 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 254,542 | $0 | 254,542 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | RYAN UNA S Director | 25,099 | $0 | 25,099 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 25,099 | $0 | 25,099 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | Marton Laurence Director | 25,099 | $0 | 25,099 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 25,099 | $0 | 25,099 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:28 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 190,000 | $0 | 190,000 (Direct) | View |
Ownership | 2024-03-08 4:26 pm | 2023-06-01 N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 0 | $0 | 142,072 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-12 7:46 pm | N/A N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 15,000 | $0 | 15,000 (Direct) | View |